QUINUCLIDINE ESTERS, INTERMEDIATE COMPOUNDS FOR ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATMENT Russian patent published in 1998 - IPC

Abstract RU 2117669 C1

FIELD: organic chemistry and technology, pharmacy. SUBSTANCE: invention relates to derivatives of 3-quinuclidyl esters of the formula (I) or its pharmaceutically acceptable acid-additive salts where X - phenyl; Y - group where A and B = 0, 1 or 2 independently; Z = 0, 1 or 2; R1 and R2- - independently hydrogen atom, -alkyl; R3 - -alkyl or phenyl. Compounds show antagonistic activity with respect to muscarinic receptors. Invention relates to also pharmaceutical composition exhibiting antimuscarinic bronchodilating effect that has above described compound or its salt at effective amount in mixture with pharmaceutically acceptable carrier or vehicle and to method of bronchodilation that involves administration of the above described compound at effective amount. Invention proposes also intermediate ester derivatives of quinuclidine of the formula (II) where X - phenyl; Y - group R1 , R2 where A, B, R3 and have values indicated above. Method of synthesis of compounds of the formula (I) involves interaction of compound of the formula (II) with strong base followed by interaction of the obtained carbanion with formaldehyde and producing compound of the formula (I) where Z = 0. If necessary, compound of the formula (I) where Z = 0 is oxidized to compound of the formula (I) where Z = 1 or 2. If necessary, compound of the formula (I) can be converted to its pharmaceutically acceptable salt. EFFECT: improved method of synthesis, enhanced effectiveness of compounds synthesized. 17 cl, 19 proc, 30 ex, 6 tbl

Similar patents RU2117669C1

Title Year Author Number
PRODRUGS OF 3-ACYL-2-HYDROXYINDOLE-1-CARBOXAMIDES, PHARMACEUTICAL COMPOSITION 1993
  • Vejn E.Bart
  • Kelvin Kuper
  • Ehdvard F.Klejnman
  • Lourens A.Rejter
  • Ral'F P.Robinson
RU2124514C1
HYDROGENATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, DERIVATIVES OF PYPERIDINE, PHARMACEUTICAL COMPOSITION AND METHOD FOR SUPPRESSING ACTIVITY OF P COMPOUND IN ORGANISM 1991
  • Manodzh S.Desaj[In]
  • Terri Dzh.Rosen[Us]
RU2105758C1
DERIVATIVES OF ACYLAMINOINDOLE AND AMINOINDOLE 1993
  • Dzhon I.Mehjkor[Us]
RU2110516C1
ARYLHYDROXYCYCLOALKENYL- AND ARYLHYDROXYIMINOCYCLOALKENYLHYDROXYUREAS AND PHARMACEUTICAL COMPOSITION INHIBITING ACTIVITY OF 5-LIPOXYGENASE 1995
  • Akiesi Kavai
  • Makoto Kavai
  • Rodni V.Stivens
RU2119479C1
DERIVATIVES OF PYRAZOLE AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF 1993
  • Uil'Jam Stiven Farasi
  • Uillard Makkovan Uehlch
RU2142946C1
3-(PIPERIDINYL-1)-CHROMANE-4,7-DIOL AND 1-(4- HYDROXYPHONYL)-2-(PIPERIDINYL-1)ALKANOL DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF BINDING NMDA RECEPTOR 1995
  • Bertrand L.Chenard
  • Todd V.Batler
RU2139857C1
N-HYDROXYLUREAS AS ANTI-INFLAMMATORY AGENTS 1995
  • Ando Akemi
  • Stivens Rodni V.
RU2152935C2
METHOD OF SYNTHESIS OF SUBSTITUTED 3-AMINOPIPERIDINE 1992
  • Terri Dzhehj Rouzen[Us]
RU2105001C1
PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1993
  • Jukhping Liang Chen
RU2124016C1
4-HETEROCYCLYL-SUBSTITUTED DERIVATIVE OF QUINAZOLINE, PHARMACEUTICAL COMPOSITION 1995
  • Li D.Arnol'D
RU2137762C1

RU 2 117 669 C1

Authors

Piter Ehdvard Kross

Alan Stobi

Dates

1998-08-20Published

1992-09-03Filed